Cite

HARVARD Citation

    Galvani, G. et al. (n.d.). MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. Digestive and liver disease. pp. S47-. [Online]. 
  
Back to record